Scenic Biotech’s Post

The expert insights in this video ring true. My key takeaways:   “You have to be agile … Genetic medicine is changing rapidly. We need to properly and appropriately give information to patients and families, but also to the next generation of providers currently implementing genomic science.” Maria Blazo, MD   “A key issue to making genomics actionable is to disseminate it .. bringing genetics more into primary care facilities where diagnoses can be recognized, orders can be placed for broad-based sequencing, and information can be appropriately interpreted for treatment.” Mark J. Kiel MD PhD   Listening to feedback from healthcare leaders helps inform our strategies and advance our mission of going beyond the science of genetics to deliver life-changing answers to the providers and patients who need them most. Thank you, Dr. Blazo and Dr. Kiel!   #genetics #heathcare

The Danaher-IGI Beacon for CRISPR Cures seeks to use the unique programmable power of #CRISPR genome editing to address hundreds of genetic diseases within a unified research, development, and regulatory framework. For more on the significance of this landmark partnership between Danaher Corporation and the Innovative Genomics Institute , check out the following: *Media coverage STAT News: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution https://lnkd.in/gj9NUuY4 Endpoints: Jennifer Doudna, Fyodor Urnov want to streamline gene editing studies with Danaher's help https://lnkd.in/gUaiMU6s Fierce Biotech: CRISPR pioneer Doudna allies with Danaher for gene editing center targeting rare disease and beyond https://lnkd.in/gUtWNJzc *Press releases Danaher - Danaher, Innovative Genomics Institute Join Forces https://lnkd.in/gEfU4dPd UCSF - New CRISPR Center Brings Hope for Rare and Deadly Disease https://lnkd.in/g5w4m9Q5 IGI - Innovative Genomics Institute and Danaher Join Forces to Accelerate and Scale Up the Development of CRISPR Cures https://lnkd.in/g7QYpapy

🚀 Exciting News in Rare Disease Research! 🚀 We are thrilled to announce that Dr. Diego Luis Medina has been awarded a research grant by the Yash Gandhi Foundation! 🏆🎉 Dr. Medina, alongside Dr. Thomas Braulke from the University Medical Center Hamburg-Eppendorf, is embarking on the ML2TREAT project. This groundbreaking research aims to identify small compounds to treat Mucolipidosis type II (ML II) using fluorescence-based high-throughput screening. 🌟🔬 At TIGEM, our High Content Screening (HCS) Facility plays a pivotal role in this and many other innovative projects. Our advanced technologies and dedicated team are making significant strides in the fight against rare genetic diseases. 💪🧬 Read more about this exciting development and the incredible work happening at TIGEM here: https://lnkd.in/duwuXU7K #RareDiseases #GeneticResearch #DrugDiscovery #TIGEM #HighContentScreening #ScientificBreakthroughs #YashGandhiFoundation #MedicalResearch

🔥🔥 Check out my interview with Dr. Michael Ackerman as we discuss genetic testing and how allied professionals can advance the care of patients with inherited rhythm disorders.🔥🔥 #genetictesting #SADS

Find ClearNote Health at the World CB & CDx Summit in Boston - and learn more about the advantages of our Virtuoso Epigenomics Platform. #CDx #drugdevelopment #therapyresponse

Women-Owned Wednesday! Today, we’re shining a spotlight on Charlotte Guzzo, COO and co-founder of Sano Genetics. Guzzo founded Sano with the goal of advancing the field of precision medicine. She and her team strive to help patients with rare, chronic diseases, such as long-COVID, multiple sclerosis (MS), and ulcerative colitis. By collecting vast swaths of genomic, clinical, and patient-reported data and connecting patients with clinical research opportunities, Sano Genetics hopes to gain a better understanding of these diseases and develop future treatment options. Keep up the great work, Charlotte! We can’t wait to see what you and your team accomplish. Source: https://hubs.li/Q02dDh6d0 #womenownedwednesday #WOW #womeninSTEM #precisionmedicine #rarediseases #chronicdiseases #SanoGenetics #ulcerativecolitis #researchopportunities #SanoDNATest

Stride into the future with Pier 23 Labs as we dedicate this May to advancing precision medicine. Explore how our personalized genetic screening can guide you to a tailor-made health strategy, unique to your DNA blueprint. It's time to take a step towards personalized healthcare that empowers and informs. #PrecisionMedicine #GeneticScreening #PersonalizedHealthcare

🙏Thank to all of those who took part in our recent survey. We got some great insights from all sorts of stakeholders involved in interpreting genetic variants when trying to find diagnoses for patients. The winner of the prize went to Héctor San Nicolás Fernández 🎉 Thanks to everyone who took part and 🙌 to you Héctor San Nicolás Fernández! #RareDisease #ClinicalGenetics #variantscientist #genetictesting #precisionmedicine

🧬 While breakthroughs in genetics have shed light on disease origins, diagnostics hasn't gotten the recognition it deserves. The COVID-19 pandemic highlighted the critical role of rapid and accurate testing. Tune into this webinar from Clarivate to explore the exciting future of diagnostics, with guests from Lucid Diagnostics, ChromaCode, Inc., Immunexpress Inc., and Igentify. https://bit.ly/4bXRFVY #Webinar #Diagnostics #PrecisionMedicine

Complex multimodal datasets require tools that can capture their full value. Principal Research Scientist Andrew McDavid, PhD, shares how using Ozette Discovery™ uncovered deeper insights from a previously published COVID-19 CITE-seq dataset. Ozette published new research exploring how Ozette Discovery™ can leverage the multimodal protein and RNA signal from #CITEseq data to identify predictors of disease severity. Download the preprint to learn how Ozette Discovery™ delivers computationally-derived insights at unmatched speed and resolution: https://loom.ly/-1DTG4g